Literature DB >> 19995646

Human papilloma virus and female lung adenocarcinoma.

Yao-Jen Li1, Yu-Chin Tsai, Yen-Ching Chen, David C Christiani.   

Abstract

Lung cancer is the leading cause of cancer among women worldwide, and adenocarcinoma is the most common histological subtype among non-smoking women. Previous studies showed that human papillomavirus (HPV) infection may relate to the tumorigenesis of pulmonary adenocarcinoma. Women with anogenital malignancy have a higher risk of lung cancer, which raises the possibility of HPV transmission from the cervix to the lung. Two postulated pathways are discussed in this work. First, HPV may infect the female cervix and then move to the lung by blood circulation. The second transmission route is the HPV infection of oral cavity resulting from dangerous sexual contacts, and subsequently transmitted to the lung. This chapter also reviews the techniques for detecting the existence, subtypes, and viral load of HPV. Future studies are needed to demonstrate the causal inference between HPV infection and the risk of female lung adenocarcinoma.

Entities:  

Mesh:

Year:  2009        PMID: 19995646     DOI: 10.1053/j.seminoncol.2009.10.002

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  13 in total

1.  Mouse mammary tumor virus-like gene sequences are present in lung patient specimens.

Authors:  Laura M Trejo-Avila; Pablo Zapata-Benavides; Raúl Barrera-Rodríguez; Isaías Badillo-Almaráz; Santiago Saavedra-Alonso; Diana E Zamora-Avila; Karla Morán-Santibañez; Jorge A Garza-Sáenz; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  Virol J       Date:  2011-09-24       Impact factor: 4.099

Review 2.  Women and lung cancer: what is new?

Authors:  Crystal M North; David C Christiani
Journal:  Semin Thorac Cardiovasc Surg       Date:  2013

3.  Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009.

Authors:  Keisha A Houston; S Jane Henley; Jun Li; Mary C White; Thomas B Richards
Journal:  Lung Cancer       Date:  2014-08-12       Impact factor: 5.705

4.  Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer.

Authors:  Tan-Hsia Chen; Chi-Chou Huang; Kun-Tu Yeh; Shu-Hau Chang; Shih-Wen Chang; Wen-Wei Sung; Ya-Wen Cheng; Huei Lee
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

5.  Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review.

Authors:  Stamatis Katsenos; Heinrich D Becker
Journal:  Case Rep Oncol       Date:  2011-03-23

6.  Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis.

Authors:  Po-Ming Chen; Ya-Wen Cheng; Yao-Chen Wang; Tzu-Chin Wu; Chih-Yi Chen; Huei Lee
Journal:  Neoplasia       Date:  2014-11-20       Impact factor: 5.715

7.  Tobacco smoke activates human papillomavirus 16 p97 promoter and cooperates with high-risk E6/E7 for oxidative DNA damage in lung cells.

Authors:  Nelson Peña; Diego Carrillo; Juan P Muñoz; Jonás Chnaiderman; Ulises Urzúa; Oscar León; Maria L Tornesello; Alejandro H Corvalán; Ricardo Soto-Rifo; Francisco Aguayo
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

8.  Reduction of microRNA-184 by E6 oncoprotein confers cisplatin resistance in lung cancer via increasing Bcl-2.

Authors:  Min-Che Tung; Po-Lin Lin; Ya-Wen Cheng; De-Wei Wu; Sauh-Der Yeh; Chi-Yi Chen; Huei Lee
Journal:  Oncotarget       Date:  2016-05-31

9.  Serum biomarkers of polyomavirus infection and risk of lung cancer in never smokers.

Authors:  Jyoti Malhotra; Tim Waterboer; Michael Pawlita; Angelika Michel; Qiuyin Cai; Wei Zheng; Yu-Tang Gao; Qing Lan; Nathaniel Rothman; Hilde Langseth; Tom K Grimsrud; Jian-Min Yuan; Woon-Puay Koh; Renwei Wang; Alan A Arslan; Anne Zeleniuch-Jacquotte; Paolo Boffetta
Journal:  Br J Cancer       Date:  2016-09-15       Impact factor: 7.640

10.  Modifiable risk factors of lung cancer in "never-smoker" women.

Authors:  Jong-Myon Bae
Journal:  Epidemiol Health       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.